文献速递认知障碍与痴呆

行为变异型额颞叶变性的生存遗传预测因素

Genetic predictors of survival in behavioral variant frontotemporal degeneration.
PubMed 文献 · Neurology · 2019-09-19

本研究回顾性分析174例行为变异型额颞叶变性(bvFTD)患者,其中57例尸检确诊、117例脑脊液支持非阿尔茨海默病理,检测C9orf72、GRN、MAPT突变。Cox回归显示致病突变与生存期缩短相关,MAPT突变关联最强且发病年龄更早。

要点

  • 致病突变携带者生存期较散发性bvFTD缩短(HR 2.164)。
  • MAPT突变生存期缩短最显著(HR 8.056),且发病年龄早于C9orf72和GRN。
  • 临床评估疾病进展时应考虑突变状态和发病年龄。

核心结论

  • 常染色体显性遗传突变与bvFTD患者生存期缩短相关,且受发病年龄调节。

研究设计与样本

  • 回顾性病历分析纳入174例临床表型为bvFTD且无相关基本神经科特征的患者,其中57例尸检确诊、117例脑脊液支持非阿尔茨海默病理。
  • 对所有患者进行C9orf72、GRN和MAPT三个常见致病突变基因分析,检出C9orf72扩增28例、GRN突变12例、MAPT突变10例。
  • 采用Cox比例风险回归检验生存与突变状态、性别、发病年龄及教育程度的关系。

主要发现

  • 全部bvFTD患者中,致病突变与生存期缩短相关(HR 2.164,95%CI 1.391–3.368)。
  • GRN突变(HR 2.423,95%CI 1.237–4.744)、MAPT突变(HR 8.056,95%CI 2.938–22.092)和C9orf72扩增(HR 1.832,95%CI 1.034–3.244)分别与散发性bvFTD相比生存期更短。
  • MAPT突变患者发病年龄早于C9orf72扩增或GRN突变(p=0.016)。

临床怎么用

  • 临床试验和临床管理在评估疾病进展时应考虑突变状态和发病年龄。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine autosomal dominant genetic predictors of survival in individuals with behavioral variant frontotemporal degeneration (bvFTD). METHODS: A retrospective chart review of 174 cases with a clinical phenotype of bvFTD but no associated elementary neurologic features was performed, with diagnosis either autopsy-confirmed (n = 57) or supported by CSF evidence of non-Alzheimer pathology (n = 117). Genetic analysis of the 3 most common genes with pathogenic autosomal dominant mutations associated with frontotemporal degeneration was performed in all patients, which identified cases with C9orf72 expansion (n = 28), progranulin (GRN) mutation (n = 12), and microtubule-associated protein tau (MAPT) mutation (n = 10). Cox proportional hazards regressions were used to test for associations between survival and mutation status, sex, age at symptom onset, and education. RESULTS: Across all patients with bvFTD, the presence of a disease-associated pathogenic mutation was associated with shortened survival (hazard ratio [HR] 2.164, 95% confidence interval [CI] 1.391, 3.368). In separate models, a GRN mutation (HR 2.423, 95% CI 1.237, 4.744), MAPT mutation (HR 8.056, 95% CI 2.938, 22.092), and C9orf72 expansion (HR 1.832, 95% CI 1.034, 3.244) were each individually associated with shorter survival relative to sporadic bvFTD. A mutation on the MAPT gene results in an earlier age at onset than a C9orf72 expansion or mutation on the GRN gene (p = 0.016). CONCLUSIONS: Our findings suggest that autosomal dominantly inherited mutations, modulated by age at symptom onset, associate with shorter survival among patients with bvFTD. We suggest that clinical trials and clinical management should consider mutation status and age at onset when evaluating disease progression.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Caswell C, McMillan CT, Xie SX, et al. Genetic predictors of survival in behavioral variant frontotemporal degeneration. Neurology. 2019. PMID: 31537715. doi:10.1212/WNL.0000000000008387

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。